Latest Regulatory News

Bass Oil Limited reported a 20% increase in August sales revenue alongside a 3.5% rise in daily production, while progressing regulatory approval for its strategic Vanessa gas field acquisition.

Island Pharmaceuticals has won a crucial FDA Type C meeting to discuss fast-tracking its antiviral Galidesivir for Marburg virus treatment, with written feedback expected by November.

Swift Networks secures a landmark Master Services Agreement with Opal HealthCare to deploy its innovative Swift TV platform across multiple aged care communities, marking a significant step in aged care technology integration.

Lunnon Metals has formalized an Ore Purchase Agreement with Gold Fields subsidiary St Ives Gold Mining, setting the stage for development of the high-grade Lady Herial gold deposit. The agreement outlines a 70, 30 free cash flow split and awaits shareholder and regulatory approvals.

CLINUVEL Pharmaceuticals has presented compelling new case studies demonstrating the efficacy of SCENESSE® in treating vitiligo, showing significant and stable repigmentation in patients. These findings, shared at the EADV conference, hint at a potential breakthrough for a condition with limited treatment options.

VHM Limited has obtained crucial federal environmental approval for its Goschen Rare Earths and Mineral Sands Project, clearing a major regulatory hurdle and setting the stage for development in 2026.

Atlas Arteria has announced a 20.0 cents per stapled security distribution for the first half of 2025, with payments scheduled for early October. The distribution reflects the company’s ongoing commitment to delivering steady returns from its international toll road assets.

Atlas Arteria has announced an ordinary dividend of AUD 0.20 per security for the six months ending June 2025, payable in early October. The dividend is fully unfranked, reflecting the company’s international income streams.

Summerset Group Holdings Limited has confirmed an ordinary dividend of NZD 0.113 per security for the half-year ending December 2025, alongside key updates to its Dividend Reinvestment Plan pricing and Australian dollar exchange rate.

The Fair Competition Commission of Tanzania has approved Shenghe Resources’ acquisition of Peak Rare Earths, clearing a major regulatory hurdle for the deal. The scheme now awaits Australian court approval and independent expert endorsement.

Peak Rare Earths has postponed its critical court hearing for Shenghe Resources' acquisition scheme due to a delay in Tanzanian regulatory approval, pushing the decision to 19 September 2025.

Generation Development Group Limited has updated its Dividend Reinvestment Plan price to AUD 6.70 per share, accompanying a fully franked ordinary dividend of 1 cent per share for the half-year ending June 2025.